BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Fuller DE, Hornfeldt CS. From Club Drug to Orphan Drug: Sodium Oxybate (Xyrem) for the Treatment of Cataplexy. Pharmacotherapy 2003;23:1205-9. [DOI: 10.1592/phco.23.10.1205.32756] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
2 Yamasaki M, Miyagawa T, Toyoda H, Khor S, Liu X, Kuwabara H, Kano Y, Shimada T, Sugiyama T, Nishida H, Sugaya N, Tochigi M, Otowa T, Okazaki Y, Kaiya H, Kawamura Y, Miyashita A, Kuwano R, Kasai K, Tanii H, Sasaki T, Honda Y, Honda M, Tokunaga K. Evaluation of polygenic risks for narcolepsy and essential hypersomnia. J Hum Genet 2016;61:873-8. [DOI: 10.1038/jhg.2016.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
3 Andlauer O, Moore H 4th, Hong SC, Dauvilliers Y, Kanbayashi T, Nishino S, Han F, Silber MH, Rico T, Einen M, Kornum BR, Jennum P, Knudsen S, Nevsimalova S, Poli F, Plazzi G, Mignot E. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012;35:1247-55F. [PMID: 22942503 DOI: 10.5665/sleep.2080] [Cited by in Crossref: 123] [Cited by in F6Publishing: 103] [Article Influence: 12.3] [Reference Citation Analysis]
4 Kotz CM. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 2006;88:294-301. [PMID: 16787655 DOI: 10.1016/j.physbeh.2006.05.031] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
5 Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, Bell JI, Strominger JL, Jones EY, Fugger L. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 2004;101:1999-2004. [PMID: 14769912 DOI: 10.1073/pnas.0308458100] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
6 DMKG Study Group. Migraine and idiopathic narcolepsy--a case-control study. Cephalalgia 2003;23:786-9. [PMID: 14510924 DOI: 10.1046/j.1468-2982.2003.00594.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
7 Huang YS, Liu FY, Lin CY, Hsiao IT, Guilleminault C. Brain imaging and cognition in young narcoleptic patients. Sleep Med 2016;24:137-44. [PMID: 27663355 DOI: 10.1016/j.sleep.2015.11.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
8 Huda MSB, Mani H, Durham BH, Dovey TM, Halford JCG, Aditya BS, Pinkney JH, Wilding JP, Hart IK. Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged. Endocrine 2013;43:696-704. [DOI: 10.1007/s12020-012-9838-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
10 Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
11 Thorpy MJ. NARCOLEPSY: . CONTINUUM: Lifelong Learning in Neurology 2007;13:101-14. [DOI: 10.1212/01.con.0000275607.54292.85] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Saletu M, Anderer P, Saletu-zyhlarz GM, Mandl M, Arnold O, Zeitlhofer J, Saletu B. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. J Neurol 2004;251:1354-63. [DOI: 10.1007/s00415-004-0543-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
13 Thorpy MJ. Sodium oxybate for the treatment of narcolepsy. Expert Opinion on Pharmacotherapy 2005;6:329-35. [DOI: 10.1517/14656566.6.2.329] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
14 Ni K, Liu Y, Zhu X, Tan H, Zeng Y, Guo Q, Xiao L, Yu B. Changed Cerebral White Matter Structural Network Topological Characters and Its Correlation with Cognitive Behavioral Abnormalities in Narcolepsy Type 1. NSS 2022;Volume 14:165-73. [DOI: 10.2147/nss.s336967] [Reference Citation Analysis]
15 Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother 2010;11:1633-45. [PMID: 20426704 DOI: 10.1517/14656566.2010.484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 Chokroverty S, Avidan AY. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2012. pp. 1634-702. [DOI: 10.1016/b978-1-4377-0434-1.00093-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sun Y, Liu M. Hypothalamic MCH Neuron Activity Dynamics during Cataplexy of Narcolepsy. eNeuro 2020;7:ENEURO. [PMID: 32303567 DOI: 10.1523/ENEURO.0017-20.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Chokroverty S. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2008. pp. 1947-2009. [DOI: 10.1016/b978-0-7506-7525-3.50110-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Møller LR, Østergaard JR. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol 2009;19:197-201. [PMID: 19364297 DOI: 10.1089/cap.2008.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
21 Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J. Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation. Vaccine 2013;31:994-1007. [DOI: 10.1016/j.vaccine.2012.12.014] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
22 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
23 Philippe A, Ma JD, Md DG, Lonlay P, Gibson K, Rabier D, Munnich A. Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (γ-hydroxybutyric aciduria). Developmental Medicine & Child Neurology 2004;46:564-8. [DOI: 10.1111/j.1469-8749.2004.tb01015.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Oliviero A, Della Marca G, Tonali PA, Pilato F, Saturno E, Dileone M, Versace V, Mennuni G, Di Lazzaro V. Functional involvement of cerebral cortex in human narcolepsy. J Neurol 2005;252:56-61. [DOI: 10.1007/s00415-005-0598-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
25 Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg T, Koehl M, Uhl G, Nishino S, Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002;23:2203-11. [DOI: 10.1016/s0196-9781(02)00251-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
26 Okun ML, Giese S, Lin L, Einen M, Mignot E, Coussons-Read ME. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun. 2004;18:326-332. [PMID: 15157949 DOI: 10.1016/j.bbi.2003.11.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
27 Pack AI. Should a Pharmaceutical Be Approved for the Broad Indication of Excessive Sleepiness? Am J Respir Crit Care Med 2003;167:109-11. [DOI: 10.1164/rccm.2211007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
28 Murata E, Kato-Nishimura K, Taniike M, Mohri I. Evaluation of the validity of psychological preparation for children undergoing polysomnography. J Clin Sleep Med 2020;16:167-74. [PMID: 31992404 DOI: 10.5664/jcsm.8158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
30 Hening WA, Allen RP, Walters AS, Chokroverty S. Motor Functions and Dysfunctions of Sleep. Sleep Disorders Medicine. Elsevier; 2009. pp. 397-435. [DOI: 10.1016/b978-0-7506-7584-0.00028-8] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
31 Jackson MW, Spencer NJ, Reed JH, Smith AJ, Gordon TP. Potentiation of a functional autoantibody in narcolepsy by a cholinesterase inhibitor. Lab Invest 2009;89:1332-9. [PMID: 19806080 DOI: 10.1038/labinvest.2009.108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Nightingale S, Orgill J, Ebrahim I, de Lacy S, Agrawal S, Williams A. The association between narcolepsy and REM behavior disorder (RBD). Sleep Medicine 2005;6:253-8. [DOI: 10.1016/j.sleep.2004.11.007] [Cited by in Crossref: 132] [Cited by in F6Publishing: 102] [Article Influence: 7.8] [Reference Citation Analysis]
33 Saletu MT, Anderer P, Saletu-zyhlarz GM, Mandl M, Arnold O, Nosiska D, Zeitlhofer J, Saletu B. EEG?mapping differences between narcolepsy patients and controls and subsequent double?blind, placebo?controlled studies with modafinil. Eur Arch Psychiatry Clin Neurosci 2005;255:20-32. [DOI: 10.1007/s00406-004-0530-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
34 Nardone R, Bergmann J, Lochner P, Caleri F, Kunz A, Staffen W, Tezzon F, Ladurner G, Trinka E, Golaszewski S. Modafinil reverses hypoexcitability of the motor cortex in narcoleptic patients: a TMS study. Sleep Med 2010;11:870-5. [PMID: 20810311 DOI: 10.1016/j.sleep.2010.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
35 Dijk D, Lockley SW. Invited Review: Integration of human sleep-wake regulation and circadian rhythmicity. Journal of Applied Physiology 2002;92:852-62. [DOI: 10.1152/japplphysiol.00924.2001] [Cited by in Crossref: 232] [Cited by in F6Publishing: 185] [Article Influence: 11.6] [Reference Citation Analysis]
36 van der Meijden WP, Fronczek R, Reijntjes RHAM, Corssmit EPM, Biermasz NR, Lammers GJ, van Dijk JG, Thijs RD. Time- and state-dependent analysis of autonomic control in narcolepsy: higher heart rate with normal heart rate variability independent of sleep fragmentation. J Sleep Res 2015;24:206-14. [DOI: 10.1111/jsr.12253] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
37 Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77. [PMID: 15128861 DOI: 10.1523/JNEUROSCI.5560-03.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
38 Overeem S, Kok SW, Lammers GJ, Vein AA, Frölich M, Meinders AE, Roelfsema F, Pijl H. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab 2003;284:E641-7. [PMID: 12453828 DOI: 10.1152/ajpendo.00421.2002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
39 Wang X. Narcolepsy induced by chronic heavy alcohol consumption: a case report. Shanghai Arch Psychiatry 2012;24:294-6. [PMID: 25328357 DOI: 10.3969/j.issn.1002-0829.2012.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Klimova B, Valis M, Talabova M, Kuchynka J, Kuca K. Pediatric Narcolepsy: A Brief Report. Clin Pediatr (Phila) 2018;57:738-40. [PMID: 28969429 DOI: 10.1177/0009922817732149] [Reference Citation Analysis]
41 Menzler K, Belke M, Unger M, Ohletz T, Keil B, Heverhagen J, Rosenow F, Mayer G, Oertel W, Möller J, Knake S. DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy. Sleep Medicine 2012;13:736-42. [DOI: 10.1016/j.sleep.2012.02.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
42 Jin L, Shi L, Zhang Y, Chen B, Wang X, Liu Y. Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China. Journal of Clinical Neuroscience 2019;63:27-31. [DOI: 10.1016/j.jocn.2019.02.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Hauri PJ. Classification of sleep disorders. Sleep Disorders. Elsevier; 2011. pp. 669-78. [DOI: 10.1016/b978-0-444-52007-4.00001-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Lammers GJ. Intranasal hypocretin-1: making sense of scents? Sleep Med 2011;12:939-40. [PMID: 22136855 DOI: 10.1016/j.sleep.2011.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
45 Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Medicine Reviews 2018;38:141-57. [DOI: 10.1016/j.smrv.2017.05.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
46 Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, Tokunaga K. An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet 2010;128:433-41. [PMID: 20677014 DOI: 10.1007/s00439-010-0862-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
47 Davey M. Investigation of sleep disorders. J Paediatr Child Health 2005;41:16-20. [DOI: 10.1111/j.1440-1754.2005.00528.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
48 Overeem S, Afink J, Bakker M, Lammers GJ, Zwarts M, Bloem BR, van Dijk JG. High frequency repetitive transcranial magnetic stimulation over the motor cortex: No diagnostic value for narcolepsy/cataplexy. J Neurol 2007;254:1459-61. [PMID: 17579803 DOI: 10.1007/s00415-007-0562-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
49 Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, Shimada M, Morishita S, Shigeta T, Lin L, Hong SC, Faraco J, Shin YK, Jeong JH, Okazaki Y, Tsuji S, Honda M, Honda Y, Mignot E, Tokunaga K. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 2008;40:1324-8. [PMID: 18820697 DOI: 10.1038/ng.231] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
50 Pardi D, Black JE. Sodium oxybate: neurobiology and clinical efficacy. Future Neurology 2006;1:721-35. [DOI: 10.2217/14796708.1.6.721] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Yamasaki M, Miyagawa T, Toyoda H, Khor SS, Koike A, Nitta A, Akiyama K, Sasaki T, Honda Y, Honda M, Tokunaga K. Genome-wide analysis of CNV (copy number variation) and their associations with narcolepsy in a Japanese population. J Hum Genet 2014;59:235-40. [PMID: 24694762 DOI: 10.1038/jhg.2014.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, Lammers GJ. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004;62:138-40. [PMID: 14718718 DOI: 10.1212/01.wnl.0000101718.92619.67] [Cited by in Crossref: 85] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
53 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
54 Nishino S, Mignot E. Narcolepsy and cataplexy. Sleep Disorders. Elsevier; 2011. pp. 783-814. [DOI: 10.1016/b978-0-444-52007-4.00007-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
55 Rangel DM, Sobreira-Neto MA, Nepomuceno CR, Marques ER, Braga-Neto P. Sleep disorders in NiemannPick disease type C, beyond cataplexy. Sleep Med 2019;57:122-7. [PMID: 30974338 DOI: 10.1016/j.sleep.2019.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Donjacour CEHM, Kalsbeek A, Overeem S, Lammers GJ, Pévet P, Bothorel B, Pijl H, Aziz NA. Altered Circadian Rhythm of Melatonin Concentrations in Hypocretin-Deficient Men. Chronobiology International 2012;29:356-62. [DOI: 10.3109/07420528.2012.655869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
57 Overeem S, Reading P, Bassetti CL. Narcolepsy. Sleep Medicine Clinics 2012;7:263-81. [DOI: 10.1016/j.jsmc.2012.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Noachtar S, Rémi J. Epilepsy and Sleep. THE EPILEPSIES 3. Elsevier; 2009. pp. 84-96. [DOI: 10.1016/b978-1-4160-6171-7.00007-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 van Dijk JG, Thijs RD, Benditt DG, Wieling W. A guide to disorders causing transient loss of consciousness: focus on syncope. Nat Rev Neurol. 2009;5:438-448. [PMID: 19597513 DOI: 10.1038/nrneurol.2009.99] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
60 Lammers GJ. Drugs Used in Narcolepsy and Other Hypersomnias. Sleep Med Clin 2018;13:183-9. [PMID: 29759269 DOI: 10.1016/j.jsmc.2018.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
61 Donjacour CE, Aziz NA, Overeem S, Kalsbeek A, Pijl H, Lammers GJ. Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study. Sleep 2014;37:795-801. [PMID: 24899766 DOI: 10.5665/sleep.3592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
62 Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neuroscience Letters 2003;341:13-6. [DOI: 10.1016/s0304-3940(03)00085-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
63 Cingoz S, Agilkaya S, Oztura I, Eroglu S, Karadeniz D, Evlice A, Altungoz O, Yilmaz H, Baklan B. Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons. Genet Test Mol Biomarkers 2014;18:261-8. [PMID: 24571861 DOI: 10.1089/gtmb.2013.0391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
64 Thijs RD, Bloem BR, van Dijk JG. Falls, faints, fits and funny turns. J Neurol 2009;256:155-67. [PMID: 19271109 DOI: 10.1007/s00415-009-0108-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
65 Overeem S, Verschuuren JJ, Fronczek R, Schreurs L, den Hertog H, Hegeman-kleinn IM, van Duinen SG, Unmehopa UA, Swaab DF, Lammers GJ. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. Journal of Neuroimmunology 2006;174:187-91. [DOI: 10.1016/j.jneuroim.2006.02.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
66 Hajak G, Geisler P. Orchestrating sleep-wake functions in the brain. Nat Med 2003;9:170-1. [DOI: 10.1038/nm0203-170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
67 Thorpy M. Therapeutic advances in narcolepsy. Sleep Med 2007;8:427-40. [PMID: 17475553 DOI: 10.1016/j.sleep.2007.03.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
68 Chen W, Zeitzer JM, Mignot E. The Hypocretins and Narcolepsy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 235-54. [DOI: 10.1007/0-387-25446-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Wang Z, Wu H. Body weight changes in early onset narcolepsy: implying compensatory mechanisms. Sleep Med 2017;32:278-9. [PMID: 28254347 DOI: 10.1016/j.sleep.2017.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci 2012;1264:72-86. [PMID: 22803681 DOI: 10.1111/j.1749-6632.2012.06585.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
71 Joo EY, Tae WS, Kim JH, Kim BT, Hong SB. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 2004;56:437-40. [DOI: 10.1002/ana.20212] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
72 Gerashchenko D, Blanco-Centurion C, Greco MA, Shiromani PJ. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003;116:223-35. [PMID: 12535955 DOI: 10.1016/s0306-4522(02)00575-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
73 Derry CP, Duncan JS, Berkovic SF. Paroxysmal Motor Disorders of Sleep: The Clinical Spectrum and Differentiation from Epilepsy. Epilepsia 2006;47:1775-91. [DOI: 10.1111/j.1528-1167.2006.00631.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
74 Holm A, Bang-Berthelsen CH, Knudsen S, Kornum BR, Modvig S, Jennum P, Gammeltoft S. miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias. Sleep 2014;37:1525-33. [PMID: 25142559 DOI: 10.5665/sleep.4004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
75 Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
76 Thorpy MJ. Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management. CNS Drugs 2006;20:43-50. [PMID: 16396523 DOI: 10.2165/00023210-200620010-00004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
77 Abad VC, Guilleminault C. Emerging drugs for narcolepsy. Expert Opinion on Emerging Drugs 2005;9:281-91. [DOI: 10.1517/14728214.9.2.281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
78 Alóe F, Azevedo AP, Hasan R. [Sleep-wake cycle mechanisms]. Braz J Psychiatry 2005;27 Suppl 1:33-9. [PMID: 16082453 DOI: 10.1590/s1516-44462005000500007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
79 Kok SW, Overeem S, Visscher TL, Lammers GJ, Seidell JC, Pijl H, Meinders AE. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res 2003;11:1147-54. [PMID: 12972686 DOI: 10.1038/oby.2003.156] [Cited by in Crossref: 128] [Cited by in F6Publishing: 104] [Article Influence: 7.1] [Reference Citation Analysis]
80 Swaab D. The human hypothalamus in metabolic and episodic disorders. Hypothalamic Integration of Energy Metabolism, Proceedings of the 24th International Summer School of Brain Research, held at the Royal Netherlands Academy of Arts and Sciences. Elsevier; 2006. pp. 3-45. [DOI: 10.1016/s0079-6123(06)53001-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
81 Sullivan SS, Guilleminault C. Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy. Expert Opin Emerg Drugs 2015;20:571-82. [PMID: 26558298 DOI: 10.1517/14728214.2015.1115480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
82 De Lecea L, Sutcliffe JG. The hypocretins and sleep: The hypocretins and sleep. FEBS Journal 2005;272:5675-88. [DOI: 10.1111/j.1742-4658.2005.04981.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
83 Thompson MD, Comings DE, Abu-ghazalah R, Jereseh Y, Lin L, Wade J, Sakurai T, Tokita S, Yoshida T, Tanaka H, Yanagisawa M, Burnham WM, Moldofsky H. Variants of theorexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am J Med Genet 2004;129B:69-75. [DOI: 10.1002/ajmg.b.30047] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
84 Shin YK, Yoon IY, Han EK, No YM, Hong MC, Yun YD, Jung BK, Chung SH, Choi JB, Cyn JG, Lee YJ, Hong SC. Prevalence of narcolepsy-cataplexy in Korean adolescents. Acta Neurol Scand 2008;117:273-8. [DOI: 10.1111/j.1600-0404.2007.00930.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
85 Thorpy MJ. Classification of Sleep Disorders. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 680-93. [DOI: 10.1016/b978-1-4160-6645-3.00060-8] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
86 Black J, Pardi D, Hornfeldt CS, Inhaber N. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Sleep Med 2009;10:829-35. [PMID: 19616998 DOI: 10.1016/j.sleep.2009.05.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
87 Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009;330:142-51. [PMID: 19363060 DOI: 10.1124/jpet.109.152009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 11.5] [Reference Citation Analysis]
88 Onofrj M, Luciano AL, Iacono D, Thomas A, Stocchi F, Papola F, Adorno D, Di Mascio R. HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease. Mov Disord 2003;18:337-40. [PMID: 12621640 DOI: 10.1002/mds.10409] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
89 Peterson PC, Husain AM. Pediatric narcolepsy. Brain and Development 2008;30:609-23. [DOI: 10.1016/j.braindev.2008.02.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
90 Fronczek R, Raymann RJ, Romeijn N, Overeem S, Fischer M, van Dijk JG, Lammers GJ, Van Someren EJ. Manipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsy. Sleep 2008;31:233-40. [PMID: 18274271 DOI: 10.1093/sleep/31.2.233] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
91 U.S. Xyrem® Multi-Center Study Group. The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) Does Not Cause Withdrawal Symptoms: ARTICLE. Journal of Toxicology: Clinical Toxicology 2003;41:131-5. [DOI: 10.1081/clt-120019128] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
92 Abad VC, Guilleminault C. Diagnosis and treatment of sleep disorders: a brief review for clinicians. Dialogues Clin Neurosci 2003;5:371-88. [PMID: 22033666 [PMID: 22033666 DOI: 10.31887/dcns.2003.5.4/vabad] [Cited by in Crossref: 18] [Article Influence: 1.8] [Reference Citation Analysis]
93 Yeh JY, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Sun CC, Wang LJ. Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan. Front Psychiatry 2020;11:205. [PMID: 32269533 DOI: 10.3389/fpsyt.2020.00205] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Tafti M, Dauvilliers Y, Overeem S. Narcolepsy and familial advanced sleep-phase syndrome: molecular genetics of sleep disorders. Current Opinion in Genetics & Development 2007;17:222-7. [DOI: 10.1016/j.gde.2007.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
95 Peraita-adrados R, García-peñas JJ, Ruiz-falcó L, Gutiérrez-solana L, López-esteban P, Vicario JL, Miano S, Aparicio-meix M, Martinez-sopena M. Clinical, polysomnographic and laboratory characteristics of narcolepsy–cataplexy in a sample of children and adolescents. Sleep Medicine 2011;12:24-7. [DOI: 10.1016/j.sleep.2010.02.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
96 Swaab DF. Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 2004;240:305-75. [PMID: 15548416 DOI: 10.1016/S0074-7696(04)40003-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
97 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
98 Rihel J, Prober DA, Schier AF. Monitoring Sleep and Arousal in Zebrafish. The Zebrafish: Cellular and Developmental Biology, Part A. Elsevier; 2010. pp. 281-94. [DOI: 10.1016/b978-0-12-384892-5.00011-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
99 Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2004;287:E630-6. [PMID: 15172887 DOI: 10.1152/ajpendo.00060.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
100 Schiappa C, Scarpelli S, D'Atri A, Gorgoni M, De Gennaro L. Narcolepsy and emotional experience: a review of the literature. Behav Brain Funct 2018;14:19. [PMID: 30587203 DOI: 10.1186/s12993-018-0151-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
101 Petrovický P, Němcová V, ten Donkelaar HJ, Overeem S, Vos P. The Reticular Formation and Some Related Nuclei. Clinical Neuroanatomy. Berlin: Springer Berlin Heidelberg; 2011. pp. 211-47. [DOI: 10.1007/978-3-642-19134-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Hirayama M, Nakamura T, Hori N, Koike Y, Sobue G. The video images of sleep attacks in Parkinson's disease. Mov Disord 2008;23:288-90. [PMID: 18044704 DOI: 10.1002/mds.21830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
103 Nelson KR, Mattingly M, Lee SA, Schmitt FA. Does the arousal system contribute to near death experience? Neurology 2006;66:1003-9. [PMID: 16606911 DOI: 10.1212/01.wnl.0000204296.15607.37] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
104 Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
105 Roelfsema F, Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocr Rev 2013;34:619-57. [PMID: 23575764 DOI: 10.1210/er.2012-1076] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
106 Nevsimalova S, Jara C, Prihodova I, Kemlink D, Sonka K, Skibova J. Clinical features of childhood narcolepsy. Can cataplexy be foretold? Eur J Paediatr Neurol 2011;15:320-5. [PMID: 21345702 DOI: 10.1016/j.ejpn.2011.01.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
107 Saletu M, Anderer P, Semlitsch HV, Saletu-zyhlarz GM, Mandl M, Zeitlhofer J, Saletu B. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Psychiatry Research: Neuroimaging 2007;154:69-84. [DOI: 10.1016/j.pscychresns.2006.04.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
108 Shan L, Bao A, Swaab DF. Changes in Histidine Decarboxylase, Histamine N-Methyltransferase and Histamine Receptors in Neuropsychiatric Disorders. In: Hattori Y, Seifert R, editors. Histamine and Histamine Receptors in Health and Disease. Cham: Springer International Publishing; 2017. pp. 259-76. [DOI: 10.1007/164_2016_125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
109 Mignot E. Narcolepsy: Pharmacology, Pathophysiology, and Genetics. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 761-79. [DOI: 10.1016/b0-72-160797-7/50071-9] [Cited by in Crossref: 12] [Article Influence: 0.7] [Reference Citation Analysis]
110 Yokogawa T, Marin W, Faraco J, Pézeron G, Appelbaum L, Zhang J, Rosa F, Mourrain P, Mignot E. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol 2007;5:e277. [PMID: 17941721 DOI: 10.1371/journal.pbio.0050277] [Cited by in Crossref: 237] [Cited by in F6Publishing: 220] [Article Influence: 16.9] [Reference Citation Analysis]
111 Bakker MJ, van Dijk JG, van den Maagdenberg AM, Tijssen MA. Startle syndromes. Lancet Neurol 2006;5:513-24. [PMID: 16713923 DOI: 10.1016/S1474-4422(06)70470-7] [Cited by in Crossref: 181] [Cited by in F6Publishing: 53] [Article Influence: 11.3] [Reference Citation Analysis]
112 Fronczek R, van Geest S, Frölich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF. Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiol Aging. 2012;33:1642-1650. [PMID: 21546124 DOI: 10.1016/j.neurobiolaging.2011.03.014] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 11.8] [Reference Citation Analysis]
113 Dzaja A, Arber S, Hislop J, Kerkhofs M, Kopp C, Pollmächer T, Polo-Kantola P, Skene DJ, Stenuit P, Tobler I, Porkka-Heiskanen T. Women's sleep in health and disease. J Psychiatr Res 2005;39:55-76. [PMID: 15504424 DOI: 10.1016/j.jpsychires.2004.05.008] [Cited by in Crossref: 139] [Cited by in F6Publishing: 115] [Article Influence: 8.2] [Reference Citation Analysis]
114 Deboer T, Overeem S, Visser NA, Duindam H, Frölich M, Lammers GJ, Meijer JH. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 2004;129:727-32. [PMID: 15541893 DOI: 10.1016/j.neuroscience.2004.07.049] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
115 Vorona RD, Ware JC. History and epidemiology of sleep-related breathing disorders. Oral Maxillofac Surg Clin North Am 2002;14:273-83. [PMID: 18088629 DOI: 10.1016/s1042-3699(02)00024-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, Butzkueven H, Lin L, Taylor BV, Speed TP, Kilpatrick TJ, Mignot E, Foote SJ. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics 2007;59:177-86. [PMID: 17256150 DOI: 10.1007/s00251-006-0183-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
117 Hong S, Lin L, Lo B, Jeong J, Shin Y, Kim S, Kweon Y, Zhang J, Einen M, Smith A, Hansen J, Grumet FC, Mignot E. DQB1*0301 and DQB1*0601 Modulate Narcolepsy Susceptibility in Koreans. Human Immunology 2007;68:59-68. [DOI: 10.1016/j.humimm.2006.10.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
118 Reutens S, Sachdev PS. Periodic limb movements and other movement disorders in sleep: Neuropsychiatric dimensions. International Review of Psychiatry 2009;17:283-92. [DOI: 10.1080/09540260500104557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
119 Didato G, Nobili L. Treatment of narcolepsy. Expert Rev Neurother 2009;9:897-910. [PMID: 19496692 DOI: 10.1586/ern.09.29] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
120 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 938-56. [DOI: 10.1016/b978-1-4160-6645-3.00084-0] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
121 Hayes D Jr. Narcolepsy with cataplexy in early childhood. Clin Pediatr (Phila) 2006;45:361-3. [PMID: 16703160 DOI: 10.1177/000992280604500409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
122 Witmans MB, Kirk VG. Infancy Onset of Symptoms of Narcolepsy in a Child. Clin Pediatr (Phila) 2002;41:609-12. [DOI: 10.1177/000992280204100809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 Lee MJ, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Sun CC, Shyu YC, Wang LJ. Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan. Sleep Med 2017;39:95-100. [PMID: 29157595 DOI: 10.1016/j.sleep.2017.07.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
124 Saletu M, Anderer P, Saletu-zyhlarz GM, Mandl M, Zeitlhofer J, Saletu B. Event-related-potential low-resolution brain electromagnetic tomography (ERP-LORETA) suggests decreased energetic resources for cognitive processing in narcolepsy. Clinical Neurophysiology 2008;119:1782-94. [DOI: 10.1016/j.clinph.2008.04.297] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
125 Kumar S, Sagili H. Etiopathogenesis and neurobiology of narcolepsy: a review. J Clin Diagn Res 2014;8:190-5. [PMID: 24701532 DOI: 10.7860/JCDR/2014/7295.4057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
126 Ahmed I, Thorpy M. Clinical Features, Diagnosis and Treatment of Narcolepsy. Clinics in Chest Medicine 2010;31:371-81. [DOI: 10.1016/j.ccm.2010.02.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
127 Kawai M, O'Hara R, Einen M, Lin L, Mignot E. Narcolepsy in African Americans. Sleep 2015;38:1673-81. [PMID: 26158891 DOI: 10.5665/sleep.5140] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
128 Mayers AG, Baldwin DS. The relationship between sleep disturbance and depression. International Journal of Psychiatry in Clinical Practice 2009;10:2-16. [DOI: 10.1080/13651500500328087] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
129 Lorenz MD, Coates JR, Kent M. Seizures, Narcolepsy, and Cataplexy. Handbook of Veterinary Neurology. Elsevier; 2011. pp. 384-412. [DOI: 10.1016/b978-1-4377-0651-2.10013-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
130 Morrison I, Riha RL. Excessive daytime sleepiness and narcolepsy — An approach to investigation and management. European Journal of Internal Medicine 2012;23:110-7. [DOI: 10.1016/j.ejim.2011.09.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
131 Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
132 Jackson MW, Reed JH, Smith AJ, Gordon TP. An autoantibody in narcolepsy disrupts colonic migrating motor complexes. J Neurosci 2008;28:13303-9. [PMID: 19052222 DOI: 10.1523/JNEUROSCI.4489-08.2008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
133 Zarowski M, Steinborn B, Gurda B, Dvorakova L, Vlaskova H, Kothare SV. Treatment of cataplexy in Niemann–Pick disease type C with the use of miglustat. European Journal of Paediatric Neurology 2011;15:84-7. [DOI: 10.1016/j.ejpn.2010.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
134 Overeem S, Taal W, Ocal Gezici E, Lammers GJ, van Dijk JG. Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiology 2004;41:254-8. [DOI: 10.1111/j.1469-8986.2003.00145.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
135 Wolf-meyer M. Precipitating Pharmakologies and Capital Entrapments: Narcolepsy and the Strange Cases of Provigil and Xyrem. Medical Anthropology 2009;28:11-30. [DOI: 10.1080/01459740802640529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
136 Rogers AE, Dreher HM. Narcolepsy. Nurs Clin North Am 2002;37:675-92. [PMID: 12587367 DOI: 10.1016/s0029-6465(02)00035-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 Koffel E, Watson D. Unusual sleep experiences, dissociation, and schizotypy: Evidence for a common domain. Clin Psychol Rev 2009;29:548-59. [PMID: 19581031 DOI: 10.1016/j.cpr.2009.06.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
138 Blanco-Centurion C, Liu M, Konadhode R, Pelluru D, Shiromani PJ. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Sleep 2013;36:31-40. [PMID: 23288969 DOI: 10.5665/sleep.2296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
139 Merritt SL, Schnyders HC, Patel M, Basner RC, O'Neill W. Pupil staging and EEG measurement of sleepiness. Int J Psychophysiol 2004;52:97-112. [PMID: 15003376 DOI: 10.1016/j.ijpsycho.2003.12.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
140 Overeem S, Lammers GJ, van Dijk JG. Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'? Sleep Med 2002;3:471-7. [PMID: 14592141 DOI: 10.1016/s1389-9457(02)00037-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
141 Robinson DM, Keating GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs 2007;21:337-54. [PMID: 17381187 DOI: 10.2165/00023210-200721040-00007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
142 Veatch OJ, Keenan BT, Gehrman PR, Malow BA, Pack AI. Pleiotropic genetic effects influencing sleep and neurological disorders. Lancet Neurol 2017;16:158-70. [PMID: 28102151 DOI: 10.1016/S1474-4422(16)30339-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
143 Miyagawa T, Toyoda H, Hirataka A, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Imai M, Fujimura Y, Tamura Y, Ikegami A, Wada Y, Moriya S, Furuya H, Kato M, Omata N, Kojima H, Kashiwase K, Saji H, Khor S, Yamasaki M, Wada Y, Ishigooka J, Kuroda K, Kume K, Chiba S, Yamada N, Okawa M, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K. New susceptibility variants to narcolepsy identified in HLA class II region. Human Molecular Genetics 2015;24:891-8. [DOI: 10.1093/hmg/ddu480] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
144 Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2005;288:E892-9. [PMID: 15625087 DOI: 10.1152/ajpendo.00327.2004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
145 Liguori C, Placidi F, Izzi F, Nuccetelli M, Bernardini S, Sarpa MG, Cum F, Marciani MG, Mercuri NB, Romigi A. Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time. Sleep Breath 2016;20:277-83. [DOI: 10.1007/s11325-015-1305-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
146 Smit LS, Lammers GJ, Catsman-berrevoets CE. Cataplexy Leading to the Diagnosis of Niemann-Pick Disease Type C. Pediatric Neurology 2006;35:82-4. [DOI: 10.1016/j.pediatrneurol.2005.12.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
147 Maski K, Steinhart E, Williams D, Scammell T, Flygare J, McCleary K, Gow M. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. J Clin Sleep Med 2017;13:419-25. [PMID: 27923434 DOI: 10.5664/jcsm.6494] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
148 Lin SJ, Crawford SY, Lurvey PL. Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan. Soc Sci Med 2005;60:617-26. [PMID: 15550309 DOI: 10.1016/j.socscimed.2004.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
149 Overeem S, Black JL 3rd, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008;12:95-107. [PMID: 18291691 DOI: 10.1016/j.smrv.2007.07.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
150 Mattarozzi K, Bellucci C, Campi C, Cipolli C, Ferri R, Franceschini C, Mazzetti M, Russo PM, Vandi S, Vignatelli L, Plazzi G. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy. Sleep Medicine 2008;9:425-33. [DOI: 10.1016/j.sleep.2007.05.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
151 Oosterloo M, Lammers GJ, Overeem S, de Noord I, Kooij JJ. Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Res 2006;143:293-7. [PMID: 16854470 DOI: 10.1016/j.psychres.2006.02.009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
152 Thorpy MJ. Classification of Sleep Disorders. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 615-25. [DOI: 10.1016/b0-72-160797-7/50058-6] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
153 Wieczorek S, Jagiello P, Arning L, Dahmen N, Epplen JT. Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA. J Mol Med (Berl) 2004;82:696-705. [PMID: 15309313 DOI: 10.1007/s00109-004-0569-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
154 Kauta SR, Marcus CL. Cases of pediatric narcolepsy after misdiagnoses. Pediatr Neurol 2012;47:362-5. [PMID: 23044019 DOI: 10.1016/j.pediatrneurol.2012.08.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
155 Donjacour CEHM, Fronczek R, Le Cessie S, Lammers GJ, Van Dijk JG. Month of birth is not a risk factor for narcolepsy with cataplexy in the Netherlands: Birth month not a risk factor for narcolepsy. Journal of Sleep Research 2011;20:522-5. [DOI: 10.1111/j.1365-2869.2011.00933.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Black JE, Brooks SN, Nishino S. Conditions of Primary Excessive Daytime Sleepiness. Neurologic Clinics 2005;23:1025-44. [DOI: 10.1016/j.ncl.2005.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
157 Zhu X, Ni K, Tan H, Liu Y, Zeng Y, Yu B, Guo Q, Xiao L. Abnormal Brain Network Topology During Non-rapid Eye Movement Sleep and Its Correlation With Cognitive Behavioral Abnormalities in Narcolepsy Type 1. Front Neurol 2020;11:617827. [PMID: 33505350 DOI: 10.3389/fneur.2020.617827] [Reference Citation Analysis]
158 Nardone R, Höller Y, Brigo F, Tezzon F, Golaszewski S, Trinka E. Transcranial magnetic stimulation and sleep disorders: pathophysiologic insights. Sleep Med 2013;14:1047-58. [PMID: 24051115 DOI: 10.1016/j.sleep.2013.04.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
159 Fuller DE, Hornfeldt CS, Kelloway JS, Stahl PJ, Anderson TF. The Xyrem?? Risk Management Program: . Drug Safety 2004;27:293-306. [DOI: 10.2165/00002018-200427050-00002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
160 Leibowitz SM, Brooks SN, Black JE. Excessive daytime sleepiness: considerations for the psychiatrist. Psychiatr Clin North Am 2006;29:921-45; abstract viii. [PMID: 17118275 DOI: 10.1016/j.psc.2006.09.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
161 Plazzi G, Serra L, Ferri R. Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev 2008;12:109-28. [PMID: 18282773 DOI: 10.1016/j.smrv.2007.08.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
162 Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54. [PMID: 23246544 DOI: 10.1016/j.vaccine.2012.12.015] [Cited by in Crossref: 159] [Cited by in F6Publishing: 140] [Article Influence: 15.9] [Reference Citation Analysis]
163 Takahashi N, Nishimura T, Harada T, Okumura A, Choi D, Iwabuchi T, Kuwabara H, Takagai S, Nomura Y, Newcorn JH, Takei N, Tsuchiya KJ. Polygenic risk score analysis revealed shared genetic background in attention deficit hyperactivity disorder and narcolepsy. Transl Psychiatry 2020;10:284. [PMID: 32801330 DOI: 10.1038/s41398-020-00971-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
164 Barros F, Aguilar ACR, Tufik S, Coelho FM. Oral L-Carnitine used to treat narcoleptic type 1 patient during pregnancy - A case report. Sleep Sci 2018;11:215-6. [PMID: 30746038 DOI: 10.5935/1984-0063.20180035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
165 Zeman A, Britton T, Douglas N, Hansen A, Hicks J, Howard R, Meredith A, Smith I, Stores G, Wilson S, Zaiwalla Z. Narcolepsy and excessive daytime sleepiness. BMJ 2004;329:724-8. [PMID: 15388615 DOI: 10.1136/bmj.329.7468.724] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
166 Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386-95. [DOI: 10.1038/nrneurol.2014.97] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
167 Perriol Μ-, Cartigny M, Lamblin M, Poirot I, Weill J, Derambure P, Monaca C. Childhood-Onset Narcolepsy, Obesity and Puberty in Four Consecutive Children: A Close Temporal Link. Journal of Pediatric Endocrinology and Metabolism 2010;23. [DOI: 10.1515/jpem.2010.23.3.257] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Overeem S, van Vliet JA, Lammers GJ, Zitman FG, Swaab DF, Ferrari MD. The hypothalamus in episodic brain disorders. The Lancet Neurology 2002;1:437-44. [DOI: 10.1016/s1474-4422(02)00191-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
169 Barson JR. Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior. Brain Res 2020;1731:145915. [PMID: 30125533 DOI: 10.1016/j.brainres.2018.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
170 Maski K, Heroux T. Beyond Daytime Sleepiness: Medical, Behavioral, Psychiatric, and Sleep Co-morbid Conditions Associated with Pediatric Narcolepsy. Curr Sleep Medicine Rep 2016;2:31-7. [DOI: 10.1007/s40675-016-0032-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Nelson KR. Near-death experience: arising from the borderlands of consciousness in crisis: Near-death experience. Ann N Y Acad Sci 2014;1330:111-9. [DOI: 10.1111/nyas.12576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]